Product Information
METHYLPHENIDATE 5 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1268 per EA under NDC 67877061601. Its NADAC has been published 266 times since Sep 1, 2021.
FDA first approved this application on Oct 4, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877061601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211779FDA Approved
10/4/2019
TE Code
AB
On Market Since
10/6/2019
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 5 MG TABLET has been published 266 times since Sep 1, 2021, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1268 per EA |
|---|---|
| All-time high | $0.1434 (Feb 11, 2026) |
| All-time low | $0.0841 (Jul 17, 2024) |
| 52-week high | $0.1434 |
| 52-week low | $0.1268 |
| Median price | $0.1138 |
| Average price | $0.1167 |
| Largest weekly change | +55.5% (Aug 21, 2024) |
| Weeks tracked | 266 |
| Tracking since | Sep 1, 2021 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylphenidate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1268 per EA (NDC 67877061601), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG TABLET has risen 6.0%. It has been tracked across 266 weekly CMS publications since Sep 1, 2021.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG TABLET?
Since Sep 1, 2021, the NADAC for METHYLPHENIDATE 5 MG TABLET has ranged from a low of $0.0841 (Jul 17, 2024) to a high of $0.1434 (Feb 11, 2026), with a median of $0.1138 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 5 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE 5 MG TABLET, is $0.0858 per EA — about 32% below METHYLPHENIDATE 5 MG TABLET.
Who manufactures METHYLPHENIDATE 5 MG TABLET?
METHYLPHENIDATE 5 MG TABLET (NDC 67877061601) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.